Clinical trial

Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow

NCT00248703

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-10-01

PhasePHASE2

Study timeline

Study start (actual)2003-10-01Date precision: month

Registry last updated2022-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

DocetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Oslo University Hospitallead sponsor

University of Tromsocollaborator

Helse Stavanger HFcollaborator

Sorlandet Hospital HFcollaborator

Sykehuset Innlandet HFcollaborator

Ullevaal University Hospitalcollaborator

Sykehuset i Vestfold HFcollaborator

Sykehuset Ostfoldcollaborator

Alesund Hospitalcollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00248703 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.